{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:25:25Z","timestamp":1757701525744},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T00:00:00Z","timestamp":1502841600000},"content-version":"vor","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jacc.2016.05.078","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T13:44:24Z","timestamp":1470750264000},"page":"727-738","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["1-Year Outcomes With Intracoronary\u00a0Abciximab in Diabetic\u00a0Patients Undergoing Primary Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"68","author":[{"given":"Raffaele","family":"Piccolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Eitel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Galasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Dominguez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan Zeeberg","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Abreu-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Piscione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2016.05.078_bib1","series-title":"IDF Diabetes Atlas, 6th edition","year":"2013"},{"key":"10.1016\/j.jacc.2016.05.078_bib2","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990-2010","volume":"370","author":"Gregg","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.05.078_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.298.7.765","article-title":"Diabetes and mortality following acute coronary syndromes","volume":"298","author":"Donahoe","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2016.05.078_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.atherosclerosis.2014.02.024","article-title":"Relationship between changes in platelet reactivity and ischemic events following percutaneous coronary intervention: a meta-regression analysis of 30 randomized trials","volume":"234","author":"Piccolo","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2016.05.078_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1253\/circj.CJ-13-0742","article-title":"Antiplatelet therapy in patients with diabetes mellitus and acute coronary syndrome","volume":"78","author":"Patti","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2016.05.078_bib6","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","volume":"118","author":"Wiviott","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.05.078_bib7","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/eurheartj\/ehq325","article-title":"PLATO Study Group. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"31","author":"James","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2016.05.078_bib8","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.114.013774","article-title":"Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial","volume":"131","author":"Cavender","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.05.078_bib9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0735-1097(99)00650-6","article-title":"Abciximab reduces mortality in diabetics following percutaneous coronary intervention","volume":"35","author":"Bhatt","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.05.078_bib10","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.4244\/EIJV9I9A186","volume":"9","author":"Piccolo","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2016.05.078_bib11","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jacc.2013.06.014","article-title":"Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial","volume":"62","author":"Desch","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.05.078_bib12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.atherosclerosis.2009.03.011","article-title":"Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention\u2013effects on soluble CD40 ligand concentrations","volume":"206","author":"Dominguez-Rodriguez","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2016.05.078_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000333117","article-title":"Intracoronary compared to intravenous abciximab in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention reduces mortality, target vessel revascularization and reinfarction after 1 year","volume":"120","author":"Iversen","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2016.05.078_bib14","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jacc.2013.01.048","article-title":"Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial","volume":"61","author":"Eitel","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.05.078_bib15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2014.06.1194","article-title":"Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction","volume":"64","author":"Eitel","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.05.078_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2013.04.011","volume":"6","author":"Serruys","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2016.05.078_bib17","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jcin.2015.06.020","article-title":"What role for glycoprotein IIb\/IIIa inhibition in contemporary coronary intervention?","volume":"8","author":"Lincoff","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2016.05.078_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jacc.2015.11.010","article-title":"Transatlantic comparison of ST-segment elevation myocardial infarction guidelines: insights from the United States and Europe","volume":"67","author":"Bainey","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.05.078_bib19","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.05.078_bib20","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS guidelines on myocardial revascularization","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2016.05.078_bib21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(11)61872-2","article-title":"Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial","volume":"379","author":"Thiele","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2016.05.078_bib22","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jacc.2015.10.005","volume":"67","author":"Levine","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.05.078_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(15)00448-1","article-title":"Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial","volume":"387","author":"Jolly","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2016.05.078_bib24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1405707","article-title":"Outcomes 1 year after thrombus aspiration for myocardial infarction","volume":"371","author":"Lagerqvist","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.05.078_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCINTERVENTIONS.113.000644","article-title":"Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: one-year results from the INFUSE-AMI trial","volume":"6","author":"Stone","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2016.05.078_bib26","doi-asserted-by":"crossref","first-page":"e003255","DOI":"10.1161\/CIRCINTERVENTIONS.115.003255","article-title":"Impact of diabetic status on outcomes after revascularization with drug-eluting stents in relation to coronary artery disease complexity: patient-level pooled analysis of 6081 patients","volume":"9","author":"Koskinas","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2016.05.078_bib27","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacc.2014.06.1182","article-title":"Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial","volume":"64","author":"Dangas","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.05.078_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.vph.2015.06.001","article-title":"Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"73","author":"Piccolo","year":"2015","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jacc.2016.05.078_bib29","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.jacc.2010.01.049","article-title":"Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction","volume":"55","author":"Eitel","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.05.078_bib30","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1136\/heartjnl-2011-300098","article-title":"Long-term prognostic value of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction","volume":"97","author":"Eitel","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2016.05.078_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcmg.2009.06.016","article-title":"Myocardial salvage by CMR correlates with LV remodeling and early ST-segment resolution in acute myocardial infarction","volume":"3","author":"Masci","year":"2010","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2016.05.078_bib32","doi-asserted-by":"crossref","first-page":"e20759","DOI":"10.1371\/journal.pone.0020759","article-title":"Efficacy and safety of\u00a0abciximab in diabetic patients who underwent\u00a0percutaneous coronary intervention with thienopyridines loading: a meta-analysis","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2016.05.078_bib33","doi-asserted-by":"crossref","first-page":"e002708","DOI":"10.1161\/JAHA.115.002708","article-title":"Sample size in clinical cardioprotection trials using myocardial salvage index, infarct size, or biochemical markers as endpoint","volume":"4","author":"Engblom","year":"2016","journal-title":"J\u00a0Am Heart Assoc"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716335586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716335586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T06:46:31Z","timestamp":1656744391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109716335586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0735109716335586"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2016.05.078","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1-Year Outcomes With Intracoronary\u00a0Abciximab in Diabetic\u00a0Patients Undergoing Primary Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2016.05.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}